XML 50 R40.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Intangible Assets (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Intangible Assets [Line Items]    
Amortization intangible by useful life, descriptions Approved medical formulas are amortized from the date NMPA approval is obtained over their individually identifiable estimated useful life, which range from ten to thirteen years.  
Amortization expense relating to intangible assets $ 97,077 $ 55,161
Transfer price $ 1.365  
Issuance of common stock 3,000,000  
Price per share $ 0.455  
Net profit sales rate 10.00%  
Percentage of net profit 15.00%  
Helpson [Member]    
Intangible Assets [Line Items]    
Percentage of net profit 15.00%  
China Pharma [Member]    
Intangible Assets [Line Items]    
Intangible asset useful life,term 20 years